Although the mechanism underlying the reduction of ZNF184 expression is not yet fully understood, reactive oxygen species (ROS) might be involved since increased ROS are commonly found in the presence of neurotoxic PD agents and α-syn PFF, triggering the neurodegenerative process in PD pathogenesis [24]. This evidence concerns the gene ZNF184 and Parkinson disease.